Comparison

LRRK2-IN-1 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Clone N/A
Amount 50 mg
Item no. HY-10875-50mg
Targets LRRK2
CASRN 1234480-84-2
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
LRRK2-IN-1 is a potent and selective LRRK2 inhibitor with IC50 of 6 nM and 13 nM for LRRK2 (G2019S) and LRRK2 (WT), respectively.
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
570.69
Clinical_Information
No Development Reported
Manufacturers Research_Area
Neurological Disease; Cancer
Solubility
DMSO : 30 mg/mL (ultrasonic)
Pathway
Apoptosis; Autophagy
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close